FDA Drug recall D-1566-2020
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmac…
- FDA Drug
- Class II
- terminated
- Published 2020-09-16
On 2020-09-16 the FDA classified a Class II recall of Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmac… by Teva Pharmaceuticals Usa, citing sub-Potent Drug: Out of specification test results for potency (below specification).
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1566-2020 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2020-08-24 |
| Published | 2020-09-16 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Teva Pharmaceuticals Usa |
| Distribution | US |
Product
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-4177-73.
Reason
Sub-Potent Drug: Out of specification test results for potency (below specification).
Identifiers
| ndc | 0093-3145-01 |
|---|---|
| ndc | 0093-3145-05 |
| ndc | 0093-3147-01 |
| ndc | 0093-3147-05 |
| ndc | 0093-4175-73 |
| ndc | 0093-4175-74 |
| ndc | 0093-4177-73 |
| ndc | 0093-4177-74 |
| code_info | Lot #: 30310638A, Exp. 02/2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1566-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.